Cumberland Pharmaceuticals's total assets for Q2 2025 were $67.91M, a decrease of -2.90% from the previous quarter. CPIX total liabilities were $40.23M for the fiscal quarter, a -3.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.